In-hospital day-by-day systolic blood pressure variability during rehabilitation: a marker of adverse outcome in secondary prevention after myocardial revascularization.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 10 6 2020
medline: 12 9 2020
entrez: 10 6 2020
Statut: ppublish

Résumé

Although it is known that increased visit-to-visit or home day-by-day variability of blood pressure (BP), independently of its average value, results in an increased risk of cardiovascular events, the prognostic value of in-hospital day-by-day BP variability in secondary cardiovascular prevention has not yet been established. We studied 1440 consecutive cardiac patients during a cardiovascular rehabilitation program of about 12 days after coronary artery bypass graft (CABG) and/or valve surgery. We measured auscultatory BP at the patient bed in each rehabilitation day twice, in the morning and the afternoon. We correlated SBP variability assessed as standard deviation (SBP-SD) and coefficient of variation (SBP-CoV) of the daily measures with overall mortality, cardiovascular mortality and major adverse cardiocerebrovascular events (MACCEs) after a mean follow-up of 49 months by Cox hazard analysis. In our patients (age 68 ± 11years, 61% hypertensive patients) the ranges of SBP-SD tertiles were: 4.1-9.1, 9.2-11.5 and 11.6-24.5 mmHg. Fifty-five percent of the patients underwent CABG, 33% underwent valve surgery, 12% both CABG and valve surgery. In CABG patients, the highest SBP-SD tertile showed the highest overall mortality, cardiovascular mortality and MACCEs (P < 0.01). Results remained significant after multivariate analysis adjusting for age, sex, mean SBP, BMI, hypertension, hyperlipidaemia, and diabetes. No association between SBP-SD and mortality or MACCEs was found in valve surgery patients. In-hospital day-by-day SBP variability predicts mortality and MACCEs in CABG patients, possibly representing a target during rehabilitation and treatment in secondary cardiovascular prevention.

Identifiants

pubmed: 32516294
doi: 10.1097/HJH.0000000000002489
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1729-1736

Auteurs

Davide Lazzeroni (D)

IRCCS Fondazione Don Carlo Gnocchi, Milan.

Umberto Camaiora (U)

Fondazione Don Carlo Gnocchi, Parma.

Paolo Castiglioni (P)

IRCCS Fondazione Don Carlo Gnocchi, Milan.

Matteo Bini (M)

Fondazione Don Carlo Gnocchi, Parma.

Silvia Garibaldi (S)

Fondazione Don Carlo Gnocchi, Parma.

Simone Geroldi (S)

Fondazione Don Carlo Gnocchi, Parma.

Luca Moderato (L)

Guglielmo da Saliceto Hospital, Piacenza.

Lorenzo Brambilla (L)

Fondazione Don Carlo Gnocchi, Parma.

Valerio Brambilla (V)

Fondazione Don Carlo Gnocchi, Parma.

Gianfranco Parati (G)

Department of Medicine and Surgery, University of Milano-Bicocca, Monza.
Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital, Milan.

Paolo Coruzzi (P)

Department of Medicine and Surgery, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH